DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia

  • Sudbø J
  • Kildal W
  • Risberg B
  • et al.
N/ACitations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Background Oral leukoplakia may develop into squamous-cell carcinoma, which has a poor prognosis. Risk factors for oral carcinoma have been identified, but there are no reliable predictors of the outcome in individual patients with oral leukoplakia. Methods We identified 150 patients with oral leukoplakia that was classified as epithelial dysplasia and measured the nuclear DNA content (ploidy) of the lesions to determine whether DNA ploidy could be used to predict the clinical outcome. Biopsy specimens obtained at annual follow-up visits were graded histologically and classified with respect to DNA content in a blinded fashion. Disease-free survival was assessed in relation to DNA ploidy and the histologic grade. The mean duration of follow-up was 103 months (range, 4 to 165). Results Among 150 patients with verified epithelial dysplasia, a carcinoma developed in 36 (24 percent). Of the 150 patients, 105 (70 percent) had diploid (normal) lesions, 20 (13 percent) had tetraploid (intermediate) lesions, and ...

Cite

CITATION STYLE

APA

Sudbø, J., Kildal, W., Risberg, B., Koppang, H. S., Danielsen, H. E., & Reith, A. (2001). DNA Content as a Prognostic Marker in Patients with Oral Leukoplakia. New England Journal of Medicine, 344(17), 1270–1278. https://doi.org/10.1056/nejm200104263441702

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free